These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3158005)

  • 1. Serotonin antagonist pirenperone inhibits sexual behavior in the male rat: attenuation by quipazine.
    Mendelson SD; Gorzalka BB
    Pharmacol Biochem Behav; 1985 Apr; 22(4):565-71. PubMed ID: 3158005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facilitatory role for serotonin in the sexual behavior of the female rat.
    Mendelson SD; Gorzalka BB
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1025-33. PubMed ID: 3161094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin type 2 antagonists inhibit lordosis behavior in the female rat: reversal with quipazine.
    Mendelson SD; Gorzalka BB
    Life Sci; 1986 Jan; 38(1):33-9. PubMed ID: 2934598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
    Meltzer HY; Simonovic M; Gudelsky GA
    Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG
    Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of alpha-melanocyte stimulating hormone on lordosis in rats: possible involvement of serotonin.
    Raible LH
    Pharmacol Biochem Behav; 1988 May; 30(1):37-43. PubMed ID: 2845440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists.
    Watson NV; Gorzalka BB
    Pharmacol Biochem Behav; 1991 Jul; 39(3):605-12. PubMed ID: 1784589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.
    Paul D; Mana MJ; Pfaus JG; Pinel JP
    Pharmacol Biochem Behav; 1988 Nov; 31(3):641-7. PubMed ID: 3251248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
    Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
    Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.
    Wolf A; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1998 Jan; 779(1-2):84-95. PubMed ID: 9473601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats.
    Pawłowski L
    J Pharm Pharmacol; 1984 Mar; 36(3):197-9. PubMed ID: 6144758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.